Skip to content

AL-SENSE 1-Step - Determination of Product Specificity

AL-SENSE 1-Step - Determination of Product Specificity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01804348
Acronym
ROM
Enrollment
150
Registered
2013-03-05
Start date
2013-04-30
Completion date
2013-08-31
Last updated
2013-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PREMATURE RUPTURE OF MEMBRANES

Keywords

PROM

Brief summary

Clinical diagnosis of amniotic fluid leak will be determined, according the hospital standard procedure, using pooling test and/or sterile speculum examination and /or pH test, and AmniSure, N-Dia, Inc. (immunoassay for diagnosis of ruptured fetal membranes (ROM)). Amniotic fluid leak test, using the AL- SENSE 1-Step device, will be considered positive in case of presence of a blue or green or grey stain on a yellow background of the AL-SENSE 1-Step, as observed by the patient and the clinician (positive/negative).

Detailed description

Pregnant women arriving at the hospital and reporting unidentified wetness (undetermined whether they sense amniotic fluid leakage or urinary incontinence) will receive a single AL-SENSE 1-Step to use up to 12 hours or until they notice any wetness. The clinician will explain the proper use and handling of the AL-SENSE 1-Step and how to read the result. In each case, the subject and the clinician/midwife (non bias to the hospital standard procedure results) will be required to read and record any occurrence of color change of the AL-SENSE 1-Step immediately after removing the test to mark if it changes color to blue or to green or to grey on the designated form. The non bias physician, who is not aware to the AL-SENSE 1-Step result (other than the clinician/midwife who records the AL-SENSE 1-Step results) will perform a diagnosis tests for amniotic fluid leak detection, according to the hospital standard procedure. The investigator will compare the AL-SENSE 1-Step results reading of the patient to the clinical diagnosis.

Interventions

DEVICEAL-SENSE 1-Step

a single AL-SENSE 1-Step to use up to 12 hours or until they notice any wetness.

Sponsors

Common Sense
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. AgE 18 years OR GREATER. 2. Subject who will sign the informed consent form. 3. Subject who arrive at the obstetric department reporting a feeling of vaginal wetness feeling (undetermined whether she sense amniotic fluid leakage or urinary incontinence).

Exclusion criteria

1. Subjects that have had sexual relations within the last 12 hours. 2. Subject is unable or unwilling to cooperate with study procedures. 3. Subject is currently participating in another clinical study

Design outcomes

Primary

MeasureTime frame
amniotic fluid leaksup to 12 hours

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026